HedgePath Pharmaceuticals, Inc.

Company: HedgePath Pharmaceuticals, Inc.

Deadline: TBD

Kaskela Law LLC is investigating HedgePath Pharmaceuticals, Inc. (“HedgePath” or the “Company”) (OTC: HPPI) on behalf of the Company’s stockholders.

The investigation seeks to determine whether members of HedgePath’s board of directors breached their fiduciary duties to the Company and its stockholders in connection with recent corporate actions, and whether HedgePath investors have been harmed as a result of such actions.

HedgePath stockholders are encouraged to contact Kaskela Law LLC at (888) 715 – 1740 to discuss this investigation and their legal rights and options, or complete the information form on this page.

Submit Your Information

  • This field is for validation purposes and should be left unchanged.